Utility of patch testing in patients with hypersensitivity syndromes associated with abacavir

AIDS

Volumn 16, Issue 16, 2002, Pages 2223-2225

  Phillips, Elizabeth J ^a,b   Sullivan, John R ^c   Knowles, Sandra R ^a   Shear, Neil H ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c SKIN AND CANCER FOUNDATION AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR;

ADULT; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC TEST; DRUG HYPERSENSITIVITY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; PATCH TEST; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROVOCATION TEST; RASH; SKIN BIOPSY;

ANTI-HIV AGENTS; BIOPSY; DIDEOXYNUCLEOSIDES; DRUG HYPERSENSITIVITY; HIV INFECTIONS; HUMANS; IMMUNOHISTOCHEMISTRY; PROSPECTIVE STUDIES; SKIN TESTS;

EID: 0037045073     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200211080-00017     Document Type: Article

References (4)

1. Escaut L, Lioteier JY, Albengres E, Cheminot N, Vittecoq D. Abacavir rechallenge has to be avoided in case of hypersensitivity reaction. AIDS 1999, 30:1419-1420.
2. Wolkenstein P, Chosidow O, Flechet ML, et al. Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis. Contact Dermat 1996, 35:234-236.
3. Mizukawa Y, Shiohara T. Effector-type CD8+ intraepidermal T cells provide a source of early IFN-γ drug eruption lesions. Allergologie 2001, 24:222.
4. Thurmond LM, Thorborn D, Ravitch J, et al. Immunohistological characterization of skin rash observed in patients on abacavir who experience a hypersensitivity reaction. Antiretrovir Ther 2000, 5 (Suppl. 5):53.